| Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study (NCT00878813) | Insel Gruppe AG, University Hospital Bern | 2009-03-01 |
| Adapting Tools to Implement Stroke Risk Management to Veterans (NCT00355147) | VA Office of Research and Development | 2009-01-01 |
| GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients (NCT00738894) | W.L.Gore & Associates | 2008-12-10 |
| VISSIT Intracranial Stent Study for Ischemic Therapy (NCT00816166) | Codman & Shurtleff | 2008-10-01 |
| International PFO Consortium (NCT00859885) | Insel Gruppe AG, University Hospital Bern | 2008-09-08 |
| The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial (NCT01020851) | Narrows Institute for Biomedical Research | 2008-09-01 |
| The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial (NCT00724724) | Peking Union Medical College Hospital | 2008-08-01 |
| Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables (NCT00698763) | Orion Corporation, Orion Pharma | 2008-08-01 |
| 3 Tesla (3T) Stroke Medical Radiologic Technology (MRT) for Examining Mismatch in 1000+ (NCT00715533) | Charite University, Berlin, Germany | 2008-07-01 |
| Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis (NCT00691314) | Peking Union Medical College Hospital | 2008-06-01 |
| Safety Study of Atomoxetine and Cerebrovascular Outcomes (NCT00634439) | Eli Lilly and Company | 2008-01-01 |
| Restless Legs Syndrome in Stroke Patients (NCT01967303) | Rambam Health Care Campus | 2008-01-01 |
| PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness (NCT00529945) | Cierra | 2007-08-01 |
| Prognostic Value of Cardiac and Renal Markers in Ischemic Stroke and Transient Ischemic Attack (NCT00479518) | University Hospital, Tours | 2007-03-01 |
| The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment) (NCT00390962) | University Hospital, Basel, Switzerland | 2006-11-01 |
| Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack (NCT00363753) | University of California, San Diego | 2006-08-01 |
| The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study (NCT00253097) | Hvidovre University Hospital | 2005-12-01 |
| Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack (NCT00251290) | Yale University | 2004-11-01 |
| Neurological Outcome With Carotid Artery Stenting (NCT00597974) | Columbia University | 2003-09-01 |
| Transient Ischemic Attack (TIA) Accelerated Diagnostic Protocol (NCT00321022) | Corewell Health East | 2003-08-01 |
| Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) (NCT00109382) | University of Calgary | 2003-05-01 |
| Neuropsychometric Outcome After Carotid Endarterectomy (NCT00597883) | Columbia University | 2003-03-01 |
| Preventing Recurrent Stroke in Minority Populations (NCT00211731) | Icahn School of Medicine at Mount Sinai | 2002-09-01 |
| Aortic Arch Related Cerebral Hazard Trial (ARCH) (NCT00235248) | Assistance Publique - Hôpitaux de Paris | 2002-02-01 |
| Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation (NCT02626871) | University of Turku | 2002-01-01 |
| Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ (NCT00600327) | Boston Scientific Corporation | 2001-12-01 |
| E-Selectin Nasal Spray to Prevent Stroke Recurrence (NCT00012454) | National Institute of Neurological Disorders and Stroke (NINDS) | 2001-03-01 |
| EVA3S: Endarterectomy Versus Angioplasty in Patients With Severe Symptomatic Carotid Stenosis (NCT00190398) | Assistance Publique - Hôpitaux de Paris | 2000-11-01 |
| VITATOPS: A Study of VITAmins TO Prevent Stroke (NCT00097669) | VITATOPS | 1998-11-01 |
| ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial (NCT00161070) | UMC Utrecht | 1997-07-01 |
| Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes (NCT01804439) | University College, London | 1997-01-01 |